Anthropic Announces AI Model Claude Autonomously Discovers CRISPR-Like Enzyme System

AI giant Anthropic has announced the discovery of a new enzyme system in bacterial DNA that it states could represent a novel gene editing mechanism similar to the groundbreaking CRISPR tool. According to the company, its flagship AI model, Claude, autonomously discovered the system after a 21-hour search through a massive database of DNA sequences.

The breakthrough occurred at Anthropic's biology research lab in San Francisco. Researchers noted that the newly found system displays characteristics found in only a handful of programmable structures, showing a pattern reminiscent of bacterial genome-editing mechanisms like CRISPR, which has previously advanced treatments for conditions such as sickle cell disease and cancer.

Anthropic CEO Dario Amodei shared on X that the company suspects this molecular machine could act as a new gene editing mechanism, emphasizing that AI is only at the beginning of driving medical breakthroughs. Stanley Qi, an associate professor of bioengineering at Stanford University, praised the discovery for its capability to recognize unusual biological patterns rapidly. However, microbiologist Kevin Blake from Washington University School of Medicine expressed scepticism, pointing out that countless CRISPR-like sequences naturally exist in unstudied bacterial species and that this find does not necessarily indicate a practical therapeutic rival to established CRISPR technology.